William Joseph Hogan

104PUBLICATIONS
258CO-AUTHORS
Haematological tumoursTransplantation immunologyGene and molecular therapyCardiology (incl. cardiovascular diseases)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (104)

|Sep 18, 2026
Venetoclax Plus Hypomethylating Agent for 7- Versus 14- Versus 21- Versus 28-Day Cycles in Newly-Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk-Stratified Analysis in 540 Patients.

|Aug 31, 2026
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

|Aug 23, 2026
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.

|Aug 19, 2026
Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial.

|Jul 25, 2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

Pageof 18

Frequent Collaborators

43 joint publications

Mrinal S Patnaik

36 joint publications

Mark R Litzow

30 joint publications

Mithun Vinod Shah

29 joint publications

Aref Al-Kali